Bruce Kramer believed that researchers need to rethink the way they test new drugs on ALS patients like him.
He argued that the double-blind testing model doesn't work for a devastating fatal illness like ALS.
In this episode of Living While Dying, we also hear from a bio-ethicist about the decision to deny some patients access to an experimental drug.
Your support matters.
You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.